An interventional study of Manual myofascial release in Healthy and Athletic Injuries, sponsored by Uskudar University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Uskudar University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 53 studies in Athletic Injuries with a site in Turkey — 10 open to participants now, 12 under way, none of them phase 3. Athletic Injuries · Turkey.
Among the 53 studies in Athletic Injuries with a site in Turkey, this one is the 4th largest by planned enrollment of the 32 interventional ones that give a count, is one of 11 that started in 2026, is one of 32 with no phase, reaches primary completion later than 7 of the 11 other live ones, and was the 53rd registered.
260 studies on the registry are indexed under Athletic Injuries; 45 are open to participants now.
Browse Athletic Injuries studies →10 of the 53 studies in Athletic Injuries with a site in Turkey are open now. Recruiting first, the newest first:
Uskudar University · Sites in Turkey
Ages 18–45
Toros University · Sites in Turkey
Ages 12–18 · Women only · Healthy volunteers
Izmir Democracy University · Sites in Turkey
Ages 18 days+
Atılım University · Sites in Turkey
Ages 15–19
Muzaffer Agir · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 22 Athletic Injuries studies recruiting now, 2 (9%) set no upper age limit and 19 (86%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 40 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 11 started in 2026.
This study's planned enrollment of 60 is above the median of 44 across 165 interventional studies indexed under Athletic Injuries.
Median enrollment 44 across the 32 interventional studies, 60 across the 21 observational. Of the 39 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 53 has an industry lead sponsor. The 10 most frequent:
Uskudar University is the lead sponsor of 173 studies on the registry; 38 are open to participants now.
Uskudar University has 4 studies filed under Athletic Injuries — fewer than ten, so there is no comparison to draw.
5 of the studies in Athletic Injuries with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07760103Uskudar UniversityCore Endurance Versus Segmental Stabilization Exercise in Recreational Athletes With Low Back Pain | 2026-12-01 |
| NCT07913217Uludag UniversityPNF Effects on Volleyball Performance | 2027-02-01 |
| NCT07705698Toros UniversityNordic vs Blood Flow Restriction Nordic Exercise in Elite Female Pole Vaulters | 2027-03 |
| NCT07941336Uskudar UniversityAcute Effects of Myofascial Release on Squat Jump Performance | 2027-03-01 |
| NCT06996990Izmir Democracy UniversityInjury Risk Factors in Volleyball Players | 2027-05-15 |
Add all 5 to your calendar (.ics) → With an account.
Among the 53 studies in Athletic Injuries with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial will investigate the acute (immediate) effects of a single session of manual myofascial release applied to lower extremity muscles on squat jump height and lower extremity joint kinematics in healthy young adults aged 18-40 years. Sixty volunteers will be randomly assigned to a myofascial release group or a control (rest) group. After a standardized warm-up, all participants will perform three maximal squat jumps. The intervention group will then receive standardized bilateral manual myofascial release to predetermined lower extremity muscle groups, while the control group will rest for an equivalent period. Squat jump testing will then be repeated under identical conditions. Jump height will be measured with the validated smartphone application My Jump 2, and hip, knee and ankle kinematics during the jump will be recorded with a Microsoft Kinect-based markerless motion analysis system.
Background: Squat jump (SJ) is a widely used field test of lower extremity explosive strength that isolates concentric force production by eliminating the countermovement. Myofascial release (MFR) is commonly used in physiotherapy and sports settings to improve range of motion and flexibility; however, its acute effects on strength, power and explosive performance vary according to technique, duration and targeted muscle group, and the effects of standardized manual MFR applied to specific lower extremity regions on jump performance and joint kinematics have not been adequately investigated.
Design: Two-arm, parallel-group, randomized controlled trial with a pre-test/post-test design. Participants will be randomly allocated 1:1 to the MFR group or the control group using a computer-generated randomization list. The study will be conducted at the Üsküdar University Physiotherapy and Rehabilitation Application and Research Center (ÜSTFİZYOTEM), Istanbul, Türkiye.
Procedures: After informed consent, demographic and descriptive data (age, sex, height, body mass, dominant lower limb, physical activity habits, injury and surgical history) will be recorded. All participants will receive an explanation of the SJ technique and a standardized warm-up. Baseline testing: participants will perform three maximal vertical squat jumps from a predetermined knee-flexion starting position with hands on hips and without countermovement, with adequate rest between trials. Jump height (cm) will be measured using the My Jump 2 smartphone application from high-speed video (take-off and landing frames). Simultaneously, hip, knee and ankle joint motion during the jump will be recorded with a Microsoft Kinect-based motion analysis system. Intervention: the MFR group will receive standardized bilateral manual myofascial release to four lower extremity muscle groups (gluteal, quadriceps, hamstring and triceps surae) using a sustained cross-hand release technique (90 seconds per muscle group per limb; total application time 12 minutes), with pressure direction, participant position and application region standardized across participants. The control group will rest quietly for an equivalent duration and will receive no manual therapy. Post-testing: immediately after the intervention or rest period, the SJ test will be repeated under identical conditions (same device, technique, position and environment).
Outcomes: The primary outcome is the change in squat jump height (cm, My Jump 2) from pre- to post-intervention. Secondary outcomes are sagittal-plane hip, knee and ankle kinematics during the squat jump obtained from the Kinect-based system: peak flexion (hip, knee) and peak dorsiflexion (ankle) angles in the starting squat position, joint angles at take-off, joint range of motion during propulsion (take-off angle minus starting angle) and, as exploratory variables, peak joint angular extension velocities during the propulsive phase.
Sample size: 60 participants (30 per group). Analysis: Normality will be assessed with the Shapiro-Wilk test, histograms and Q-Q plots. Descriptive data will be presented as mean ± SD or median (IQR) and counts (%). The primary outcome will be analyzed with a two-way mixed-design repeated-measures ANOVA (group × time), with the group × time interaction as the main indicator of the acute effect of MFR; post-hoc pairwise comparisons with correction for multiple comparisons will be performed when appropriate. Non-parametric alternatives will be used if assumptions are violated. Secondary kinematic variables will be analyzed in the same way. Significance will be set at p \< 0.05; effect sizes and 95% confidence intervals will be reported.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Standardized warm-up and baseline squat jump testing, followed by a single session of standardized bilateral manual myofascial release applied to predetermined lower extremity muscle groups, followed by post-intervention squat jump testing under identical conditions.
Other: Manual myofascial release
Standardized warm-up and baseline squat jump testing, followed by 12 minutes of quiet seated rest (equivalent to the myofascial release application time), followed by post-test squat jump testing under identical conditions. No manual therapy is applied.
A single session of manual myofascial release applied bilaterally by a physiotherapist to four lower extremity muscle groups: gluteal muscles (prone), quadriceps (supine), hamstrings (prone) and triceps surae (prone). Technique: sustained cross-hand myofascial release with slow, low-load pressure applied in the direction of tissue restriction until a tissue release is felt, held for 90 seconds per muscle group per limb (4 muscle groups × 2 limbs × 90 s = 12 minutes total), without oil or lubricant. Order of application (gluteal → hamstring → triceps surae → quadriceps), participant position, direction of pressure and duration are standardized for all participants. Applied immediately after baseline squat jump testing; post-testing follows within 2 minutes after the application.
Also known as: Myofascial release technique; MFR
Change in squat jump height
Vertical squat jump height (cm) measured with the My Jump 2 smartphone application from high-speed video using flight time (take-off and landing frames). Best of three trials (or mean, as predefined in the protocol). Higher values indicate better jump performance.
Time frame: Baseline (pre-intervention) and immediately after the intervention/rest period (approximately 15-20 minutes after baseline, same session)
Change in peak hip flexion angle in the starting squat position
Sagittal-plane peak hip flexion angle (degrees) in the predetermined starting squat position immediately before propulsion, recorded with a Microsoft Kinect-based markerless motion analysis system; mean of three trials.
Time frame: Baseline and immediately after the intervention/rest period (same session)
Change in peak knee flexion angle in the starting squat position
Sagittal-plane peak knee flexion angle (degrees) in the starting squat position, Kinect-based system; mean of three trials.
Time frame: Baseline and immediately after the intervention/rest period (same session)
Change in sagittal-plane ankle, hip and knee kinematics during the squat jump
Composite set of sagittal-plane kinematic variables recorded with a Microsoft Kinect-based markerless motion analysis system (mean of three trials): (a) peak ankle dorsiflexion angle in the starting squat position (degrees); (b) hip, knee and ankle joint angles at the instant of take-off, defined as the last frame of foot contact (degrees); (c) hip, knee and ankle range of motion during the propulsive phase, calculated as take-off angle minus starting-position angle (degrees); and (d) peak hip, knee and ankle angular extension velocities during the propulsive phase (degrees/second), reported as exploratory given the 30 Hz sampling rate.
Time frame: Baseline and immediately after the intervention/rest period (same session)
Plan to share: Undecided — De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.
Start is estimated for Dec 2026; primary completion for Mar 2027, 2 months later.
Of 121 non-industry interventional studies with no phase under Athletic Injuries, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 14. This study's planned 2 months is below that.
Counting every sponsor, half of 123 studies reached it within 5 months; a quarter within 2 and three quarters within 14.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.